Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Olefin Compound. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115417782A reveals a green nickel-catalyzed chain walking method for olefin reduction, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN106518674A reveals nickel-catalyzed olefin synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes.
Patent CN109761810B details a solvent-free ball milling method for oxidative Heck coupling, offering high yields and rapid synthesis for pharmaceutical intermediates.
Patent CN109761810B reveals a solvent-free oxidative Heck reaction using mechanical grinding. This breakthrough enables high-yield synthesis of inactive olefin aryl compounds with significant cost and time reductions.
Patent CN116332900B reveals a catalyst-free olefin synthesis using visible light. Offers cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN112851456A details a mild base-catalyzed route converting alcohols to olefins using SO2F2, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106938983B reveals nickel-catalyzed olefin synthesis. Achieve cost reduction in fine chemical manufacturing with high-purity intermediates and scalable processes.
Patent CN118084596B enables visible light catalytic hydrogenation of aromatic olefins. Achieve high-purity intermediates with reduced costs and mild reaction conditions for scalable manufacturing.
Novel electrochemical method replaces gold catalysts for trans-olefin production. High purity, room temperature process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover how nickel-catalyzed carbon-carbon coupling enables high-yield, cost-effective synthesis of benzhydryl piperazine intermediates for pharmaceuticals, eliminating strict anhydrous conditions and reducing supply chain risks.